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Polymeric Scaffolds for Tissue Engineering
One of the principal challenges in the field of tissue engineer-
ing has been the inability to produce tissue constructs with an 
intrinsic vasculature, a requirement for most complex vascular-
ized tissues and organs.1,2 Approaches to address this challenge 
include the use of angiogenic growth factors in tissue engineering 
scaffolds,3 seeding scaffolds with stem cells to generate micro-
vasculature4,5 as well as the formation of structures comprising 
three-dimensional microfluidic networks pre-seeded with endo-
thelial cells.6-8 For this latter approach, one of the most important 
considerations is the selection of an appropriate polymeric scaf-
folding material, possessing suitable mechanical, chemical and 
biodegradation characteristics for the specific application. Initial 
development of microfluidic constructs for vascularized tissues 
utilized Poly(Di-Methyl-Siloxane) (PDMS),6 an elastomer com-
monly employed in lab-on-a-chip applications. While PDMS is 
optically transparent, flexible and biocompatible,9 it is not biode-
gradable and the surface chemistry can be unstable,10 rendering 
it unsuitable for implantable applications. A series of biodegrad-
able polymers have been explored as scaffolding materials for 
vascularized tissue engineering, including PLGA,11 PGS12,13 and 
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silk fibroin.14,15 However, for applications requiring flexible yet 
strong scaffolds with long half-lives, these materials exhibit either 
non-ideal mechanical properties (PLGA, silk) or excessively rapid 
degradation (PGS), highlighting the need for degradable poly-
mer substrates with tunable properties for engineered tissues and 
implants.
To develop a longer-lasting scaffold substrate than PGS 
while preserving its excellent chemical and mechanical proper-
ties, a new class of biodegradable elastomers, poly(ester amide), 
poly(1,3-diamino-2-hydroxypropane-co-polyol sebacate) (APS), 
has been developed.16 This class of APS materials is tunable 
across a wide range of chemical compositions, resulting in degra-
dation times between 6 weeks and one year, which are governed 
by a range of different degradation mechanisms. The mate-
rial has been shown to be highly biocompatible, with primary 
hepatocyte culture showing extended cell functionality without 
requiring deposition of protein coatings on the surface, and ame-
nable to nanostructuring to provide surface topographic features 
representative of the cell microenvironment.17 In this work, we 
present new data on the APS polymer system relevant for tis-
sue engineering applications, including microfabrication results 
for microfluidic channel networks for comparison with existing 
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a microfluidic network within the tissue engineering scaffold; 
an initial proof of principle for this concept was demonstrated 
using nondegradable PDMS as the substrate for endothelialized 
microfluidic networks.6 Early demonstrations of biodegradable 
microfluidic devices were reported by Armani and Liu,21 King et 
al.11 and Liu and Bhatia.22 The former report required the inser-
tion of a nondegradable metallic layer for bonding the degrad-
able PLGA films; the latter two were constructed solely from 
biodegradable PLGA. These structures suffered from excessive 
mechanical stiffness, spurring the development of biodegrad-
able elastomers such as PGS. The relatively short half-life of 
PGS has led to further development of APS as a tunable biode-
gradable elastomer for tissue engineering applications; here we 
present the first report of a microfluidic network formed from 
the APS polymer.
The technical approach here is similar to that reported for 
PLGA,11 PGS12,13 and silk fibroin.14,15 Briefly, a simple microchan-
nel network design was generated based on principles of micro-
vascular flow, pressure and wall shear stress.23 This microchannel 
network is based upon design principles including uniform flow 
and distribution of oxygen and nutrients throughout a scaffold 
layer, as well as physiologic levels of pressure drop and wall shear 
stress within the various vessel sizes in the network. The net-
work was translated into a photolithographic layout for fabrica-
tion, with the intent of producing a single-layer microvascular 
network.
The process begins with silicon master mold fabrication using 
SU-8 photolithography, with minimum channel dimensions of 
35 microns in depth and 30 microns in width, on the order of the 
size scale of capillaries. The channel depth is set by the thickness 
of the SU-8 photolithographic layer, and is constant through-
out the entire 2D network. The channel width is varied across 
the network, to reflect the size scales of the various vessels in the 
arterial and venous circulation. Once the lithographic pattern is 
formed on the silicon master surface, the wafer must be prepared 
for polymer molding by depositing a surface coating that can be 
removed sacrificially to release the molded polymer layer. For 
PGS, the optimal surface coating was found to be sucrose dis-
solved in water, but process development with APS determined 
that the temperatures involved in curing resulted in unaccept-
ably high levels of sucrose caramelization during the process. 
Therefore, we investigated alternative sacrificial sugar coatings 
and determined that maltose has a caramelization temperature 
about 20°C higher than sucrose. Therefore, maltose coatings 
were deposited onto the silicon masters to assist in delamination 
of APS films, and APS was cast onto the silicon master molds and 
then lifted off as a free-standing film. A channel layer was bonded 
to a flat APS layer and the layers joined at elevated temperature 
and pressure. The challenge for layer bonding is to form a strong, 
irreversible and leakproof bond between films, without raising 
the temperature or pressure so high as to deform or collapse the 
microchannels or other high resolution structures. In order to 
prepare the bonded devices for future flow testing and cell seed-
ing, silicone tubing was attached to the APS microfluidic scaffold 
to demonstrate flow through the network at physiological pres-
sures (0–180 mmHg).
degradable polymer systems. These data demonstrate that the 
APS system represents a novel class of polymers for the develop-
ment of microfluidic scaffolds for tissue engineering applications.
Background
Biodegradable polymers. Among the commonly used biode-
gradable polymers, polyesters and polyamides have shown great 
potential in part because of their controlled degradation proper-
ties. Both typically degrade via hydrolysis, and polyester gener-
ally degrades comparatively faster than polyamides.18 Based on 
these observations, a rationale for the development of APS was 
generated. For many tissue engineering and implantable device 
applications, a long half-life and durable properties are desired. 
The class of APS polymers was developed as a mixture of polyes-
ter and polyamide, providing a tunable and extended half-life. It 
was reported to have mass loss of around 13% after 20 weeks,16 a 
much slower degradation rate than PGS, which had a mass loss 
of around 17% after 60 days (roughly 9 weeks).19
As previously mentioned, existing biodegradable polymers 
have properties optimized for specific clinical applications, but 
many of the commonly used materials degrade fairly rapidly.20 
Another issue seen especially in polyamides is exceedingly high 
stiffness (e.g., nylons), which is a challenge for applications 
requiring flexibility and malleability based on surgical consider-
ations. Finally, many biodegradable polymers have a limited abil-
ity to attach chemical moieties to the surface, a serious problem 
because of the need for chemical functionalization in order to 
facilitate cell attachment. Compared with existing biodegradable 
polymers, the strengths of APS include a slower, tunable degrada-
tion rate, the production of bioabsorbable monomers, excellent 
mechanical properties and compatibility with cell culture, all of 
which suggest that APS is an excellent polymer substrate for tis-
sue engineering use.
Specific properties of APS. The polymer investigated here is 
from a class of new biodegradable elastomeric poly(ester amide)s, 
poly(1,3-diamino-2-hydroxypropane-co-polyol sebacate)s (APS),16 
which have been developed as an alternative to the traditional 
crosslinked aliphatic polyesters to address the above-mentioned 
drawbacks. It is composed of nontoxic, inexpensive mono-
mers commonly used in biomedical systems. The relatively low 
Young’s modulus and tunable biodegradation half-life enable the 
material to attain biomimetic mechanical properties similar to 
those of extra-cellular matrix (ECM), and to have compatibil-
ity with dynamic mechanical environments. The participation 
of the polymer in hydrogen bonding also allows for subsequent 
conjugation reactions and cell seeding and adhesion. The hydro-
lysis rate and elastic modulus of the polymer can both be tuned 
using different amide percentage. It is also susceptible to enzy-
matic degradation, where the degradation rate of both the ester 
groups and amide groups can be individually and precisely trig-
gered using different enzymes.
Biodegradable microfluidics. One of the principal chal-
lenges in tissue engineering is the formation of a vasculature 
to support oxygen and nutrient transport within the growing 
tissue. One avenue for achieving this goal is the formation of 
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Results
Mechanical testing. Mechanical properties of APS and PGS 
have been measured and are summarized in Table 1. Along with 
the Young’s modulus and elasticity, the synthesis properties and 
degradation rate are characterized for both materials. The table 
indicates that APS is slightly stronger and less elastic than PGS, 
but that the synthesis process is more controlled and the degrada-
tion rate much slower.
As shown in Figure 1, it was found that the curing time, the 
curing temperature and the thickness of scaffold are all signifi-
cant factors in the formation of APS 
scaffolds. It was shown that the 
longer APS curing time and higher 
curing temperature makes scaf-
folds with higher tensile strength. 
It was also found that there is an 
exponential relationship between 
elastic modulus and scaffold thick-
ness across a range of curing times. 
Regardless of the curing tempera-
ture, the elasticity decreased expo-
nentially as thickness was increased 
for fixed curing times. There was 
also a linear relationship between 
tensile strength and the UTS of 
APS.
Microfluidic scaffolds. As 
shown in Figure 2, a simple con-
struct comprising an APS micro-
fluidic channel was utilized for 
this first demonstration. The APS 
microchannel network layer was 
placed against a flat APS sheet, with 
a PDMS structural support placed 
underneath the flat sheet. The PDMS structural support 
was there simply for tubing stability but is not required, 
since the future embodiment of the device will incor-
porate tubing directly connected to the APS layers. The 
microfabricated channels in APS are shown in Figure 
3, where the film exhibits high fidelity reproduction 
of the silicon master channel features down to the 30 
micron feature size. There is no evidence of channel dis-
tortion due to the de-molding process, although SEM 
analysis is now underway to determine the precise fea-
ture dimensions relative to those on the master wafer. 
Finally, Figure 4 shows the bonded APS construct with 
the flat film and the microchannel film, each at the full 
100 mm diameter size, laminated together in prepa-
ration for flow testing and eventual cell seeding. The 
quality of the layer bonding across the full wafer size 
appears to be excellent.
Table 1. Comparison between PGS and APS
Biodegradable polymer name PGS APS
Synthesis Time (Hours) 77 13
Degree of Polymerization of 
Pre-polymer
Inconsistent Consistent
Young’s Modulus (MPa) ~0.282 ~4.34
Ultimate Tensile Strength (MPa) >0.5 ~1.69 MPa
Strain to Failure (%) ~200% ~70%
Degradation rate ~17% in 60 days ~13% in 20 weeks
Figure 1. The variation between thicknesses of scaffolds and mechanical strength (regardless of the cur-
ing temperature) exhibited exponential correlation. With the same amount of curing time, the elasticity 
decreases exponentially as thicknesses increases.
Figure 2. A schematic diagram for the design of the microfluidic device built in 
APS. Top material is the flat PDMS scaffold for tubing stabilization. Middle scaffold 
is the flat APS scaffold. Bottom scaffold is the patterned APS scaffold.
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present study, we report on the development of a spe-
cific process for biodegradable microfluidic devices con-
structed from APS, an alcohol-based poly(ester amide) 
elastomer, which possesses a much lower degradation 
rate but retains elastomeric properties for tissue scaf-
fold applications. The process reported here is capable 
of forming microfluidic channels on a wafer-scale with 
strong layer-to-layer bonds and well-preserved microscale 
architecture. As the biocompatibility of APS in vivo 
was also shown in the study done by Bettinger et al.,24 
it was demonstrated that the material could be used for 
resorbable tissue engineering devices for the purpose of 
drug delivery and regenerative medicine. The next steps 
for this investigation will focus on the establishment of 
robust flow conditions within the devices, seeding of 
endothelial cells to form a functional microvascular net-
work and implantation studies to explore in vivo biocom-
patibility, host integration and long-term degradation 
properties for this scaffolding material.
Materials and Methods
APS synthesis. Synthesis of poly(1,3-diamino-2-hydroxy-
propaneco-glycerol sebacate) elastomers. All materials were 
purchased from Sigma Aldrich (St. Louis, MO) and 
used as received unless otherwise specified. A round bot-
tom flask was charged with 0.06 mol of 1,3-diamino-
2-hydroxy-propane (DAHP), 0.03 mol glycerol (G) and 
0.09 mol of sebacic acid (SA) to produce a molar ratio of 
2:1:3 of DAHP:G:SA, respectively. The reactants were 
heated under an argon blanket at 130°C for 3 h. The 
pressure was then dropped to approximately 50 mTorr 
and the contents were allowed to react for 10 h at 130°C. 
The product was then stored under a desiccant environ-
ment until further use. The product was spread onto sili-
con wafer molds and glass slides and cured at 170°C at 
approximately 50 mTorr for either 24 h or 48 h. Film 
thicknesses of either 0.5 mm or 1 mm were achieved by 
applying the reaction product at surface densities of 100 
mg/cm2 and 200 mg/cm2, respectively.
PGS synthesis. PGS pre-polymer was synthesized by 
step growth polymerization of 0.1 mole each of glycerol 
(Aldrich, Milwaukee, WI) and sebacic acid (Aldrich) as 
previously described.19 The resulting product was stored 
under a desiccant environment as is for later use. The 
product was spread onto silicon wafer molds and glass slides and 
cured at 160°C at approximately 50 mTorr for times ranging 
from 8 to 24 h.
Both APS and PGS films were delaminated in ddH
2
O at 
70°C for 18 h. Sol was removed by incubating polymer films in 
100% ethanol for 24 h followed by washing and incubation with 
ddH
2
O. Subsequent characterization techniques were performed 
on sol-free samples only.
Mechanical testing. The thicknesses of APS films were deter-
mined by measuring at the five separate points across the sample 
with a dial gauge (L.S. Starrett, Athol, MA). The samples were 
Discussion and Conclusion
The concept of biodegradable microfluidic devices was first intro-
duced using PLGA in by Armani and Liu21 and King et al.11 but 
these device constructs exhibited a high degradation rate, low 
elasticity and concerns regarding immune and inflammatory 
response in bulk format. More recently, Fidkowski et al.12 and 
Bettinger et al.13 constructed PGS-based devices that exhibit 
much more desirable mechanical properties for implantation, but 
the relatively high degradation rate of the polymer limits its appli-
cability for certain long-lasting applications as an implant. In the 
Figure 3. Microfluidic channels mimicking blood vessel bifurcated networks 
built in APS. Scale bar in the image is 100 μm.
Figure 4. Full microfluidic channel device in APS. Scale bar in the image is 1 cm.
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cut to size (approximately 2.0 x 20.0) mm2 and mounted on 
an Electroforce ELF 3200 mechanical tester (Bose-Enduratec, 
Framingham, MA) with a 250 g load cell (model 31-1435-03; 
Sensotech, Columbus, OH). The samples were elongated to failure.
Microfabrication of microfluidic scaffolds. The silicon mold 
was designed and created as previously described by Bettinger et 
al.13 Prior to replica molding of APS, a sacrificial maltose release 
layer was spin-coated on the silicon master. Photolithographically 
patterned silicon masters were cleaned using piranha solution 
(Mallinckrodt, St. Louis, MO) and oxygen plasma-cleaned 
(March, St. Petersburg, FL) at 250 mTorr and 200 W for 45 
seconds. A 90% (w/w) solution of maltose (Sigma, St. Louis, 
MO) in water was spin-coated at 2,500 revolutions per minute 
for 30 s. The maltose layer was pre-baked on a hot plate at 95°C 
for 120 seconds. 7.00 ± 0.05 g of APS prepolymer was melted at 
170°C and applied to the wafers for replica molding and smooth 
sheet formation. The thickness of the final APS film could be 
adjusted simply by varying the mass of prepolymer used. The 
prepolymer was cured at 170°C for 48 h under 50 mTorr of vac-
uum, which produced a crosslinked sheet in which a portion of 
the hydroxyl and carboxylic acid functional groups remained. 
The APS sheets were delaminated by statically incubating the 
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60°C for 24 h beginning immediately after polymer curing. 
Diffusion of water between the polymer/silicon interfaces led 
to maltose dissolution and eventual delamination. Sheets were 
trimmed and punched to achieve appropriate fluidic connections 
between layers. Microfluidic layers were stacked, aligned and 
bonded together simultaneously by oxygen plasma treatment for 
surface activation, followed by curing the polymer at 170°C for 
24 h under 50 mTorr of vacuum. An additional layer of PDMS 
was laminated onto the device for tubing stabilization. Once the 
final curing step was completed, silicone tubing (1/16 in. inner 
diameter, 1/8 in. outer diameter, Cole-Parmer) was inserted into 
the devices in a sterile environment. Luer-Lok connections were 
inserted into the tubing, and the base of the connections was 
sealed with epoxy (McMaster-Carr). In some cases, additional 
PDMS structures were added to the inlet and outlet to prevent 
dissociation of the tubing from the device.
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